P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

Clinical trial NCT06014762 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06014762
Sponsor: Poseida Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified High-grade B-cell Lymphoma Primary Mediastinal Large B-cell Lymphoma (PMBCL)Transformed Follicular Lymphoma (tFL)Follicular Lymphoma Grade 3B DLBCL DLBCL - Diffuse Large B Cell Lymphoma DLBCL Arising From Follicular Lymphoma DLBCL, Diffused Large B Cell Lymphoma DLBCL NOS

Start date: 2024-04-16
Primary completion: 2029-03-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.